Log in

NASDAQ:RARXRa Pharmaceuticals News Headlines

$47.99
0.00 (0.00 %)
(As of 04/2/2020)
Add
Compare
Today's Range
$47.99
Now: $47.99
$47.99
50-Day Range
$47.99
MA: $47.99
$48.00
52-Week Range
$19.64
Now: $47.99
$48.02
Volume30,200 shs
Average Volume1.16 million shs
Market Capitalization$2.27 billion
P/E RatioN/A
Dividend YieldN/A
Beta1.05

Headlines

Ra Pharmaceuticals (NASDAQ RARX) News Headlines

Source:
DateHeadline
Ra Pharmaceuticals Inc (NASDAQ:RARX) Given Consensus Rating of "Hold" by BrokeragesRa Pharmaceuticals Inc (NASDAQ:RARX) Given Consensus Rating of "Hold" by Brokerages
www.americanbankingnews.com - June 1 at 2:34 AM
Ra Pharmaceuticals Inc (NASDAQ:RARX) Receives Average Rating of "Hold" from BrokeragesRa Pharmaceuticals Inc (NASDAQ:RARX) Receives Average Rating of "Hold" from Brokerages
www.americanbankingnews.com - May 7 at 2:06 AM
Ra Pharmaceuticals EPS misses by $0.16Ra Pharmaceuticals EPS misses by $0.16
seekingalpha.com - February 27 at 12:18 PM
Ra Pharmaceuticals Announces Publication of Zilucoplan Phase 2 gMG Trial Results in JAMA NeurologyRa Pharmaceuticals Announces Publication of Zilucoplan Phase 2 gMG Trial Results in JAMA Neurology
finance.yahoo.com - February 18 at 7:40 AM
Ra Pharmaceuticals is Now Oversold (RARX)Ra Pharmaceuticals is Now Oversold (RARX)
www.nasdaq.com - February 10 at 1:13 PM
Ra Pharmaceuticals and Camurus Announce Exclusive License Agreement for FluidCrystal® Extended Release Formulation ofRa Pharmaceuticals and Camurus Announce Exclusive License Agreement for FluidCrystal® Extended Release Formulation of
www.bloomberg.com - January 5 at 4:30 PM
Ra Pharma commences mid-stage study of zilucoplan in rare type of myopathyRa Pharma commences mid-stage study of zilucoplan in rare type of myopathy
seekingalpha.com - December 4 at 9:25 AM
Moore Kuehn, PLLC Encourages Liberty Property Trust (LPT), Proteon Therapeutics (PRTO), Ra Pharmaceuticals (RARX), Carolina Trust BancShares (CART), and Highlands Bankshares (HLND) Investors to Contact FirmMoore Kuehn, PLLC Encourages Liberty Property Trust (LPT), Proteon Therapeutics (PRTO), Ra Pharmaceuticals (RARX), Carolina Trust BancShares (CART), and Highlands Bankshares (HLND) Investors to Contact Firm
finance.yahoo.com - December 3 at 6:15 PM
Merger Investigation Alert: Halper Sadeh LLP Investigates Whether The Sale Of These Companies Is Fair To Shareholders - IPHS, FOMX, RARXMerger Investigation Alert: Halper Sadeh LLP Investigates Whether The Sale Of These Companies Is Fair To Shareholders - IPHS, FOMX, RARX
finance.yahoo.com - November 26 at 1:02 PM
INVESTOR ALERT: Monteverde & Associates PC Continues its Investigation on the Following TransactionINVESTOR ALERT: Monteverde & Associates PC Continues its Investigation on the Following Transaction
finance.yahoo.com - November 22 at 5:23 PM
SHAREHOLDER ALERT: Monteverde & Associates PC Reminds Investors of its Ongoing Inquiry Regarding the AcquisitionSHAREHOLDER ALERT: Monteverde & Associates PC Reminds Investors of its Ongoing Inquiry Regarding the Acquisition
finance.yahoo.com - November 19 at 5:10 PM
Shareholder Investigation Alert: Halper Sadeh LLP Investigates Whether the Sale of These Companies Is Fair to Shareholders – WLH, CISN, RARX, TECDShareholder Investigation Alert: Halper Sadeh LLP Investigates Whether the Sale of These Companies Is Fair to Shareholders – WLH, CISN, RARX, TECD
www.benzinga.com - November 16 at 9:50 AM
Shareholder Investigation Alert: Halper Sadeh LLP Investigates Whether the Sale of These Companies Is Fair to Shareholders – WLH, CISN, RARX, TECDShareholder Investigation Alert: Halper Sadeh LLP Investigates Whether the Sale of These Companies Is Fair to Shareholders – WLH, CISN, RARX, TECD
finance.yahoo.com - November 16 at 9:50 AM
Ra Pharmaceuticals EPS misses by $0.05, beats on revenueRa Pharmaceuticals EPS misses by $0.05, beats on revenue
seekingalpha.com - November 7 at 8:26 AM
Ra Pharmaceuticals Reports Third Quarter 2019 Financial Results and Provides Corporate UpdateRa Pharmaceuticals Reports Third Quarter 2019 Financial Results and Provides Corporate Update
finance.yahoo.com - November 7 at 8:26 AM
Is Ra Pharmaceuticals, Inc. (RARX) Going To Burn These Hedge Funds ?Is Ra Pharmaceuticals, Inc. (RARX) Going To Burn These Hedge Funds ?
finance.yahoo.com - October 28 at 11:27 PM
MERGER ALERT – ACHN, RARX, and IPHS: Levi & Korsinsky, LLP Notifies Investors of Investigations Concerning the Sale of these CompaniesMERGER ALERT – ACHN, RARX, and IPHS: Levi & Korsinsky, LLP Notifies Investors of Investigations Concerning the Sale of these Companies
finance.yahoo.com - October 28 at 1:21 PM
Stock Holdings in Callon Petroleum, Ra Pharmaceuticals, and MoreStock Holdings in Callon Petroleum, Ra Pharmaceuticals, and More
finance.yahoo.com - October 26 at 5:44 PM
Alexion Delivers With Achillion Acquisition; Good Deal To Protect Its Mainstay DrugAlexion Delivers With Achillion Acquisition; Good Deal To Protect Its Mainstay Drug
seekingalpha.com - October 24 at 10:11 PM
SHAREHOLDER INVESTIGATION ALERT: Halper Sadeh LLP Continues To Investigate Whether The Sale Of These Companies Is Fair To Shareholders - RARX, DOVA, ACHNSHAREHOLDER INVESTIGATION ALERT: Halper Sadeh LLP Continues To Investigate Whether The Sale Of These Companies Is Fair To Shareholders - RARX, DOVA, ACHN
finance.yahoo.com - October 18 at 5:08 PM
RARX, ROAN, and FCSC SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of BuyoutsRARX, ROAN, and FCSC SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of Buyouts
finance.yahoo.com - October 17 at 2:12 PM
SHAREHOLDER NOTICE: Brodsky & Smith, LLC Announces an Investigation of Ra Pharmaceuticals, Inc. (NASDAQ GS: RARX)SHAREHOLDER NOTICE: Brodsky & Smith, LLC Announces an Investigation of Ra Pharmaceuticals, Inc. (NASDAQ GS: RARX)
finance.yahoo.com - October 16 at 10:28 PM
RA PHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Ra Pharmaceuticals, Inc. - RARXRA PHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Ra Pharmaceuticals, Inc. - RARX
finance.yahoo.com - October 14 at 10:46 PM
Ra Pharma Stock Doubles On $2.5B Buyout Deal With Belgian Biopharma UCBRa Pharma Stock Doubles On $2.5B Buyout Deal With Belgian Biopharma UCB
finance.yahoo.com - October 10 at 3:53 PM
Ra Pharmaceuticals Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Sale of Ra Pharmaceuticals, Inc. is Fair to Shareholders; Investors Are Encouraged to Contact the Firm – RARXRa Pharmaceuticals Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Sale of Ra Pharmaceuticals, Inc. is Fair to Shareholders; Investors Are Encouraged to Contact the Firm – RARX
finance.yahoo.com - October 10 at 3:53 PM
RA PHARMACEUTICALS, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of BuyoutRA PHARMACEUTICALS, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout
finance.yahoo.com - October 10 at 3:53 PM
SHAREHOLDER ALERT: WeissLaw LLP Investigates Ra Pharmaceuticals, Inc.SHAREHOLDER ALERT: WeissLaw LLP Investigates Ra Pharmaceuticals, Inc.
finance.yahoo.com - October 10 at 3:53 PM
Bragar Eagel & Squire, P.C. is Investigating the Board of Directors of Ra Pharmaceuticals, Inc. (NASDAQ: RARX) on Behalf of Ra Pharma Shareholders and Encourages Ra Pharma Investors to Contact the FirmBragar Eagel & Squire, P.C. is Investigating the Board of Directors of Ra Pharmaceuticals, Inc. (NASDAQ: RARX) on Behalf of Ra Pharma Shareholders and Encourages Ra Pharma Investors to Contact the Firm
finance.yahoo.com - October 10 at 3:53 PM
Ra Pharma acquired for $2.1B by Belgian firm that vows to grow in BostonRa Pharma acquired for $2.1B by Belgian firm that vows to grow in Boston
finance.yahoo.com - October 10 at 3:53 PM
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Regarding Whether the Sale of Ra Pharmaceuticals, Inc. to UCB S.A. is Fair to ShareholdersSHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Regarding Whether the Sale of Ra Pharmaceuticals, Inc. to UCB S.A. is Fair to Shareholders
finance.yahoo.com - October 10 at 3:53 PM
4 Stocks With More Than 20% Price Increases on Thursday4 Stocks With More Than 20% Price Increases on Thursday
finance.yahoo.com - October 10 at 3:53 PM
Belgiums UCB to acquire Ra Pharma in cash deal valued at about $2.5 billionBelgium's UCB to acquire Ra Pharma in cash deal valued at about $2.5 billion
www.marketwatch.com - October 10 at 10:53 AM
Are Shareholders Getting Enough From the Ra Pharma Acquisition?Are Shareholders Getting Enough From the Ra Pharma Acquisition?
247wallst.com - October 10 at 10:53 AM
RA Pharmaceuticals Soars on Deal to Be Acquired for $2.1 BillionRA Pharmaceuticals Soars on Deal to Be Acquired for $2.1 Billion
www.thestreet.com - October 10 at 10:53 AM
Belgium's UCB to acquire Ra Pharma in cash deal valued at about $2.5 billionBelgium's UCB to acquire Ra Pharma in cash deal valued at about $2.5 billion
finance.yahoo.com - October 10 at 10:53 AM
The Daily Biotech Pulse: UCB To Buy Ra Pharma, Reata Reacquires Rights To Nrf2 Activators From AbbVie, BioNTech IPOThe Daily Biotech Pulse: UCB To Buy Ra Pharma, Reata Reacquires Rights To Nrf2 Activators From AbbVie, BioNTech IPO
finance.yahoo.com - October 10 at 10:53 AM
Ra Pharma (RARX) Alert: Johnson Fistel Investigates Proposed Sale of Ra Pharmaceuticals; Is $48 a Fair Price?Ra Pharma (RARX) Alert: Johnson Fistel Investigates Proposed Sale of Ra Pharmaceuticals; Is $48 a Fair Price?
finance.yahoo.com - October 10 at 10:53 AM
This Biotech Stock Just Doubled After Snagging A $2.1 Billion Takeover DealThis Biotech Stock Just Doubled After Snagging A $2.1 Billion Takeover Deal
finance.yahoo.com - October 10 at 10:53 AM
UCB to Buy Ra for $2.5 Billion to Double Down in Rare DiseaseUCB to Buy Ra for $2.5 Billion to Double Down in Rare Disease
www.bloomberg.com - October 10 at 5:53 AM
Belgium's UCB to buy Ra Pharmaceuticals for $2.1 blnBelgium's UCB to buy Ra Pharmaceuticals for $2.1 bln
finance.yahoo.com - October 10 at 5:53 AM
UPDATE 1-Belgium's UCB to buy Ra Pharmaceuticals in $2.1 bln cash dealUPDATE 1-Belgium's UCB to buy Ra Pharmaceuticals in $2.1 bln cash deal
finance.yahoo.com - October 10 at 5:53 AM
UCB to acquire Ra Pharmaceuticals in $2.1 billion dealUCB to acquire Ra Pharmaceuticals in $2.1 billion deal
finance.yahoo.com - October 10 at 5:53 AM
UCB Agrees to Acquire Ra Pharmaceuticals: Joining Forces to Improve Treatment Options for People Living With Myasthenia Gravis and Other Rare DiseasesUCB Agrees to Acquire Ra Pharmaceuticals: Joining Forces to Improve Treatment Options for People Living With Myasthenia Gravis and Other Rare Diseases
www.businesswire.com - October 10 at 4:33 AM
Achillion Makes Significant Advancement With FDA Designation, Sets Up Big Catalysts In Coming MonthsAchillion Makes Significant Advancement With FDA Designation, Sets Up Big Catalysts In Coming Months
seekingalpha.com - October 9 at 4:15 PM
BRIEF-Ra Pharmaceuticals Announces Dosing Of First Patient In Global Phase 3 Pivotal Study Of Zilucoplan For gMGBRIEF-Ra Pharmaceuticals Announces Dosing Of First Patient In Global Phase 3 Pivotal Study Of Zilucoplan For gMG
www.msn.com - October 2 at 9:00 PM
Ra pharmaceuticals launches late-stage zilucoplan trial for gMGRa pharmaceuticals launches late-stage zilucoplan trial for gMG
seekingalpha.com - October 2 at 4:00 PM
Ra Pharmaceuticals Announces Dosing of First Patient in Global Phase 3 Pivotal Study of Zilucoplan for gMGRa Pharmaceuticals Announces Dosing of First Patient in Global Phase 3 Pivotal Study of Zilucoplan for gMG
finance.yahoo.com - October 2 at 8:12 AM
Ra Pharmaceuticals Announces Selection for the First ALS Platform Trial by the Sean M. Healey & AMG Center for ALS at Mass GeneralRa Pharmaceuticals Announces Selection for the First ALS Platform Trial by the Sean M. Healey & AMG Center for ALS at Mass General
finance.yahoo.com - September 18 at 9:00 AM
BRIEF-Ra Pharmaceuticals Earns Clinical Development Milestone For Oral Macrocyclic Peptide CandidateBRIEF-Ra Pharmaceuticals Earns Clinical Development Milestone For Oral Macrocyclic Peptide Candidate
www.msn.com - August 22 at 11:36 AM
Ra Pharma earns milestone from Merck on start of early-stage studyRa Pharma earns milestone from Merck on start of early-stage study
seekingalpha.com - August 21 at 9:09 AM
This page was last updated on 6/1/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.